This is the last of the three-part podcast series, Keeping up with the Chemos on tisotumab vendotin.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on tisotumab vendotin.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue tisotumab vendotin. Once again, the session ends with take home points for patient monitoring while on tisotumab vendotin.  Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith Smith, PharmDSpeakers:Julia Canestraro, OD, FAAOShannon Westin, MD Erin Hickey Zacholski, PharmDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.